{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "403",
                "469"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w"
        },
        {
            "identifier": "T2",
            "position": [
                "474",
                "492"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Cewnikowanie serca"
        },
        {
            "identifier": "T3",
            "position": [
                "495",
                "515"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zabiegiem zamkni\u0119cia"
        },
        {
            "identifier": "T4",
            "position": [
                "516",
                "522"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ubytku"
        },
        {
            "identifier": "T5",
            "position": [
                "523",
                "563"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zestawem Amplatzer Septal Occluder 14 mm"
        },
        {
            "identifier": "T6",
            "position": [
                "564",
                "581"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "w dniu 15.10.2018"
        },
        {
            "identifier": "T7",
            "position": [
                "751",
                "761"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolina"
        },
        {
            "identifier": "T8",
            "position": [
                "764",
                "770"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Clexan"
        },
        {
            "identifier": "T9",
            "position": [
                "773",
                "779"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T10",
            "position": [
                "889",
                "912"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Kontrola kardiologiczna"
        },
        {
            "identifier": "T11",
            "position": [
                "913",
                "926"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za ok. 3 m-ce"
        },
        {
            "identifier": "T12",
            "position": [
                "941",
                "948"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesanu"
        },
        {
            "identifier": "T13",
            "position": [
                "949",
                "965"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "30 mg codziennie"
        },
        {
            "identifier": "T14",
            "position": [
                "966",
                "982"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "przez 6 miesi\u0119cy"
        },
        {
            "identifier": "T15",
            "position": [
                "1201",
                "1263"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku przegrody przedsionk\u00f3w"
        },
        {
            "identifier": "T16",
            "position": [
                "1393",
                "1403"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolina"
        },
        {
            "identifier": "T17",
            "position": [
                "1405",
                "1414"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "kropl\u00f3wka"
        },
        {
            "identifier": "T18",
            "position": [
                "1554",
                "1557"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "VSD"
        },
        {
            "identifier": "T19",
            "position": [
                "1572",
                "1592"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zabiegu operacyjnego"
        },
        {
            "identifier": "T20",
            "position": [
                "1595",
                "1612"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergiczny"
        },
        {
            "identifier": "T21",
            "position": [
                "1613",
                "1621"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "uczulona"
        },
        {
            "identifier": "T22",
            "position": [
                "1635",
                "1649"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T23",
            "position": [
                "1650",
                "1663"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:Z95.8",
            "identifier": "N2",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Obecno\u00c5\u009b\u00c4\u0087 innych implant\u00c3\u00b3w i przeszczep\u00c3\u00b3w sercowo-naczyniowych"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N3",
            "referenced": "T4",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N4",
            "referenced": "T15",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N5",
            "referenced": "T18",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N6",
            "referenced": "T19",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N7",
            "referenced": "T20",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "icd": "ICD10:Z91.0",
            "identifier": "N8",
            "referenced": "T21",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenie na czynniki inne ni\u00c5\u00bc leki i substancje biologiczne w wywiadzie"
        },
        {
            "arg1": "T11",
            "arg2": "T10",
            "identifier": "R15",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T12",
            "arg2": "T13",
            "identifier": "R16",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T14",
            "arg2": "T12",
            "identifier": "R17",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T4",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T23",
            "arg2": "T22",
            "identifier": "R24",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T20",
            "arg2": "T22",
            "identifier": "R26",
            "subtype": "Alg",
            "type": "R"
        },
        {
            "arg1": "T21",
            "arg2": "T22",
            "identifier": "R27",
            "subtype": "Alg",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T3",
            "identifier": "R3",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T5",
            "identifier": "R4",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T2",
            "identifier": "R5",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 4 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie V: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w.\\x0aCewnikowanie serca z zabiegiem zamkni\u0119cia ubytku zestawem Amplatzer Septal Occluder 14 mm w dniu 15.10.2018\\x0aQ21.1, Z95.8|Rozpoznanie IV: |Rozpoznanie III:\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolina , Clexan , Acesan.\n------------------------------------------------\nZalecenia\n------------------------------------------------\nKontrola kardiologiczna za ok. 3 m-ce.\nPrzyjmowanie Acesanu 30 mg codziennie przez 6 miesi\u0119cy.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku przegrody przedsionk\u00f3w.\\x0aQ21.1\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolina, kropl\u00f3wka.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\ndziewczynka z VSD skierowana do zabiegu operacyjnego , wywiad alergiczny uczulona na laktoz\u0119 , lek\u00f3w na sta\u0142e nie otrzymuje\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia\n    NR-KS:G-18/019883\n    KODKRESKOWYPROBKI:G-18/019883\n    GR:B\n    RH:+ (dodatni)\n    FENOTYP:K-\n    P-CIALA:Przeciwcia\u0142 odporno\u015bciowych dla antygen\u00f3w krwinek czerwonych nie stwierdzono.\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia\n    NR-KS:G-18/019981\n    KODKRESKOWYPROBKI:G-18/019981\n    GR:B\n    RH:+ (dodatni)\n    FENOTYP:K-\n    P-CIALA:Przeciwcia\u0142 odporno\u015bciowych dla antygen\u00f3w krwinek czerwonych nie stwierdzono.\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:6.25[10^3/ul]\n    RBC Krwinki czerwone:4.20[10^6/ul]\n    HGB Hemoglobina:11.7[g/dl]\n    HCT Hematokryt:33.3[%]\n    MCV wska\u017anik czerwonokrw:79.3[fl]\n    MCH wska\u017anik czerwonokrw:27.9[pg]\n    MCHC wska\u017anik czerwonokr:35.1[g/dl]\n    PLT z morfologii:285[10^3/ul]\n    RDW-SD:40.4[fl]\n    RDW-CV:14.2[%]\n    PDW:9.9[fl]\n    MPV:9.5[fl]\n    P-LCR:20.6[%]\n    PCT (hematokryt p\u0142ytkowy:0.27[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:2.15[10^3/ul]\n    NEUTR%:34.4[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:3.34[10^3/ul]\n    LYMPH%:53.4[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.56[10^3/ul]\n    MONO%:9.0[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.16[10^3/ul]\n    EO%:2.6[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.04[10^3/ul]\n    BASO%:0.6[%]\n    NRBC %:0.0[%]\n    NRBC #:0.00[10^3/ul]\nCzas kaolinowo-kefalinowy (APTT): APTT-SP:30.2[sek]\nCzas protrombinowy (PT)\n    Czas protrombinowy:12.4[sek]\n    Wska\u017anik PT:88.7[%]\n    INR:1.13\nFibrynogen: Fibrynogen:2.58[g/L]\nD-dimer - test ilo\u015bciowy: D-dimer - test ilo\u015bciowy:280[ng/ml]\nALAT: ALAT:20[U/L]\nASPAT: ASPAT:32[U/L]\nBilirubina ca\u0142kowita (TBil): Bilirubina ca\u0142kowita:0.79[mg/dl]\nKreatynina + GFR\n    Kreatynina w surowicy:0.27[mg/dl]\n    eGFR stand. wg Schwartza:207.8[ml/min/1,73 m^2]\n    eGFR zmod. wg Schwartza:156.0[ml/min/1,73 m^2]\n    wzrost:102[cm]\nMocznik: Mocznik:26[mg/dl]\nProfil parametr\u00f3w krytycznych (ABL)\n    pH:7.355\n    pCO2:36.2[mmHg]\n    BE:-4.70[mmol/L]\n    HCO3:19.7[mmol/L]\n    pO2:57.6[mmHg]\n    O2Sat:91.8[%]\n    S\u00f3d (ABL):136[mmol/L]\n    Potas (ABL):4.4[mmol/L]\n    Chlorki (ABL):111[mmol/L]\n    Wap\u0144 zjonizowany (ABL):1.25[mmol/L]\n    Ht - ABL:36.0[%]\n    Hb - ABL:11.7[g/dl]\n    FO2Hb:89.6[%]\n    FCOHb:1.4[%]\n    FMetHb:1.0[%]\n    FHbF:0.0[%]\n    Glukoza (ABL):82[mg/dl]\n    Mleczany:14[mg/dl]\nProfil parametr\u00f3w krytycznych (ABL)\n    pH:7.412\n    pCO2:32.9[mmHg]\n    BE:-2.80[mmol/L]\n    HCO3:20.6[mmol/L]\n    pO2:97.0[mmHg]\n    O2Sat:98.3[%]\n    S\u00f3d (ABL):140[mmol/L]\n    Potas (ABL):4.5[mmol/L]\n    Chlorki (ABL):110[mmol/L]\n    Wap\u0144 zjonizowany (ABL):1.26[mmol/L]\n    Ht - ABL:35.4[%]\n    Hb - ABL:11.5[g/dl]\n    FO2Hb:96.1[%]\n    FCOHb:1.0[%]\n    FMetHb:1.2[%]\n    Glukoza (ABL):90[mg/dl]\n    Mleczany:15[mg/dl]\nNT-proBNP surowica: NT-proBNP w surowicy:56[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nZ95.8\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n37.21\n88.721\n35.711\n89.541\n88.761\n------------------------------------------------"
}